Hypersensitivity pneumonitis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Hypersensitivity pneumonitis}} {{CMG}} == Overview == ==References== {{reflist|2}} Category:Disease Category:Pulmonology Category:Occupational Hazard {{Resp...")
 
No edit summary
 
(9 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Hypersensitivity pneumonitis}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hypersensitivity_pneumonitis]]


{{CMG}}
{{CMG}}


== Overview ==
== Overview ==
The differential diagnosis of hypersensitivity pneumonitis is, primarily, a group of diseases known as idiopathic interstitial pneumonia. This group of diseases includes [[idiopathic pulmonary fibrosis]] (IPF) (which manifests histologically as usual interstitial pneumonia), idiopathic non-specific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia, among others. There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of Hypersensitivity Pneumonitis.


==Differential Diagnosis==
* HP occurs due to inhalation of organic agents .
* Several diseases can occur due to this and mimic HP.
* These disorders are as follows:
** '''Inhalation fever:'''
*** Patients present with [[fever]], [[chills]], [[headache]], and [[myalgias]].
*** There are no pulmonary findings (although mild [[dyspnea]] may occur).<ref name="pmid12645092">{{cite journal |vauthors=Antonini JM, Lewis AB, Roberts JR, Whaley DA |title=Pulmonary effects of welding fumes: review of worker and experimental animal studies |journal=Am. J. Ind. Med. |volume=43 |issue=4 |pages=350–60 |date=April 2003 |pmid=12645092 |doi=10.1002/ajim.10194 |url=}}</ref>
*** Onset is 4-8 hours following exposure. 
*** No long-term symptoms.
**'''Organic dust toxic syndrome:'''
***This syndrome occurs due to of exposure to bioaerosols contaminated with toxin-producing fungi (mycotoxins).<ref name="pmid7587416">{{cite journal |vauthors=Lougheed MD, Roos JO, Waddell WR, Munt PW |title=Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins |journal=Chest |volume=108 |issue=5 |pages=1196–200 |date=November 1995 |pmid=7587416 |doi= |url=}}</ref><ref name="pmid8681637">{{cite journal |vauthors=Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA |title=Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects |journal=Chest |volume=110 |issue=1 |pages=263–70 |date=July 1996 |pmid=8681637 |doi= |url=}}</ref><ref name="pmid46192">{{cite journal |vauthors=Emanuel DA, Wenzel FJ, Lawton BR |title=Pulmonary mycotoxicosis |journal=Chest |volume=67 |issue=3 |pages=293–7 |date=March 1975 |pmid=46192 |doi= |url=}}</ref>
***Patients present with [[fever]], [[chills]], and [[myalgias]] 4-6 hours after exposure. <ref name="pmid8131466">{{cite journal |vauthors=Malmberg P, Rask-Andersen A, Rosenhall L |title=Exposure to microorganisms associated with allergic alveolitis and febrile reactions to mold dust in farmers |journal=Chest |volume=103 |issue=4 |pages=1202–9 |date=April 1993 |pmid=8131466 |doi= |url=}}</ref>
***In contrast to inhalation fever, the chest X ray may show diffuse opacities.
***Bronchiolitis or diffuse alveolar damage may be present on lung biopsy specimens.
***This is not a true form of HP because no prior sensitization is required.
**'''Chronic bronchitis:'''
***This is a very severe form of pulmonary disease.
***Most common respiratory disorder among agricultural workers.
***The prevalence of chronic bronchitis is much higher  at 10%, compared with 1.4% for HP.
**'''Exposure to aerosolized Mycobacterium avium complex (MAC):'''
***Occurs due to exposure to aerosolized mycobacterium avium complex (MAC).
***[[Hot tub lung]] is a term used to describe these hypersensitivity pneumonitis-like cases because they have generally been associated with hot tub use.
***The syndrome has been linked to the high levels of infectious aerosols containing MAC organisms found in the water. Whether this syndrome represents a true MAC infection or classic HP remains controversial (Marras, 2005).


By '''frequency of Interstitial Lung Diseases''' (Xaubet, 2004):
# [[Idiopathic pulmonary fibrosis]] (38.6%)
# [[Sarcoidosis]] (14.9%)
# [[Cryptogenic organizing pneumonitis|Cryptogenic organizing pneumonia]] (10.4%)
# Interstitial lung disease associated with collagen vascular diseases (9.9%)
# [[Hypersensitivity Pneumonitis]] (HP) (6.6%)
# Unclassified (5.1%)
'''In alphabetical order:'''
*[[Air-conditioner lung]]
*[[Aspergillus clavatus]]
*[[Bagassosis]]
*[[Bird breeder's lung]]
*[[Bird fancier's lung]]
*[[Cheese worker's lung]]
*[[Chemical worker's lung]]
*[[Cladosporium]]
*[[Farmer's lung]]
*[[Grain handler's lung]]
*[[Humidifier lung]]
*[[Malt worker's lung]]
*[[Micropolyspora faeni]]
*[[Mollusk shell hypersensitivity]]
*[[Mucor stolonifer]]
*[[Paprika splitter's lung]]
*[[Penicillium casei]]
*[[Saccharopolyspora rectivirgula]]
*[[Sitophilus granarius]]
*[[Thermoactinomyces sacchari]]
*[[Thermoactinomyces vulgaris]]
Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, bronchitis, hypersensitivity pneumonitis, pneumoconiosis.
<small>
{| class="wikitable"
! style="background:#4479BA; color: #FFFFFF;" align="center" |Pulmonary Function Test
! style="background:#4479BA; color: #FFFFFF;" align="center" |Obstructive Lung Disease
! style="background:#4479BA; color: #FFFFFF;" align="center" |Restrictive Lung Disease
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |TLC
|'''↑'''
|↓
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |RV
|'''↑'''
|↓
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FVC
|↓
|↓
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FEV1
|↓↓
|↓
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |FEV1/FVC
|↓
|N to '''↑'''
|-
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |MVV
|↓
|↓
|}
</small>
===Approach to Lung Disorders===
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | A01 | | | | | | | | | |A01=Spirometry}}
{{familytree | | | | | | | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | |}}
{{familytree | | | | | | B01 | | | | | | | | | | | | | | B02 | | | |B01=Low FEV1/FVC ratio|B02=Normal to high FEV1/FVC ratio|}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | | | | | | C01 | | | | | | | | | | | | | | C02 | | | |C01=Obstructive Lung Disease|C02=Restrictive Lung Disease|}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | |D01=Bronchodilator therapy|D02=DLCO}}
{{familytree | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | }}
{{familytree | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| }}
{{familytree | E01 | | | | | | | | E02 | | | | E03 | | | | | | | | E04 | | |E01=Increased FEV1|E02=No change in FEV1|E03=Normal DLCO|E04=Decreased DLCO|}}
{{familytree | |!| | | | | | | | | |!| | | | | |!| | | | | | | | | |!| | | }}
{{familytree | F01 | | | | | | | | F02 | | | | F03 | | | | | | | | F04 | | |F01=Asthma|F02=COPD|F03=Chest wall disorders|F04=Interstitial Lung Disease|}}
{{familytree/end}}
====Spirometry Findings in Various Lung Conditions====
[[image:Figure 39 03 05f.jpg|thumb|center|Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])]]
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="2" rowspan="3" |Disease
! colspan="11" |Clinical manifestations
! colspan="5" |Diagnosis
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="4" |Symptoms
! colspan="7" |Physical exam
! rowspan="2" |Lab findings
! colspan="3" |Imaging
!Gold standard
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Cough
!Dyspnea
!Hemoptysis
!Fever
!History/Exposure
!Cyanosis
!Clubbing
!JVD
!Peripheral edema
!Auscultation
!Other prominent findings
!CXR
!CT
!DLCco
!
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |Hypersensitivity Pneumonitis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* History of [[allergen]] exposure
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Diffuse fine bibasilar [[crackles]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Constitutional symptoms
** [[Weight loss]]
** Anorexia
** Muscle weakness
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Neutrophilia
* Elevated [[ESR]]
* Elevated [[CRP]]
* Elevated [[immunoglobulin]]
* No peripheral blood [[eosinophilia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Poorly defined micronodular or diffuse interstitial pattern
* In chronic form
** Fibrosis
** Loss of lung volume
** Coarse linear opacities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Ground-glass opacities '''or'''
* Diffusely increased radiodensities
* Diffuse micronodules
* Focal air trapping
* Mosaic perfusion
* Occasionaly thin-walled cysts
* Mild fibrotic changes 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
*Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Acute respiratory distress syndrome|Acute Respiratory Distress Syndrome]] ([[Acute respiratory distress syndrome|ARDS]])
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Trauma]]
* [[Sepsis]]
* [[Drug overdose]]
* [[Blood transfusion|Massive transfusion]]
* [[Acute pancreatitis]] [[Aspiration]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Coarse [[breath sounds]]
* Rhonchi [[crackles]]
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Initially [[respiratory alkalosis]] transforming to respiratory acidosis
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[BNP]] level of less than 100 pg/mL
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
* [[Leukopenia]]
* [[Leukocytosis]]
* [[Thrombocytopenia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Bilateral pulmonary infiltrates
** Initially patchy peripheral
** Later diffuse bilateral
* Ground glass
* Frank alveolar infiltrate
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Bronchial dilatation within areas of ground-glass opacification
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* PaO<sub>2</sub> '''/''' FiO<sub>2</sub> <300
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="2" |[[Bronchitis]]
|Acute
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Diffuse [[Wheeze|wheezes]]
* High-pitched continuous sounds
* The use of accessory muscles 
* Prolonged expiration
* [[Rhonchi]]
* [[Rales]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Hoarseness]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Normal
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Clinical diagnosis
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|Chronic
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* A positive history of chronic productive [[cough]] 
* Shortness of breath 
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Prolonged expiration; [[wheezing]]
* Diffusely decreased breath sound
* Coarse [[crackles]] with inspiration
* Coarse [[rhonchi]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Chronic [[hypoxemia]] may lead to [[polycythemia]] 
* Increase in [[Neutrophil|Neutrophils]] count
* Chronic [[respiratory acidosis]].
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Radiolucency
* Diaphragmatic flattening due to hyperinflation
* Increased retrosternal airspace on the lateral radiograph
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*N/A
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |[[Occupational lung disease|Pneumoconiosis]]<ref name="pmid9563720">{{cite journal |vauthors=Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ |title=Idiopathic pulmonary fibrosis: predicting response to therapy and survival |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1063–72 |year=1998 |pmid=9563720 |doi=10.1164/ajrccm.157.4.9703022 |url=}}</ref>
|[[Occupational lung disease|SIlicosis]]<ref name="pmid16545629">{{cite journal |vauthors=du Bois RM |title=Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis |journal=Clin. Chest Med. |volume=27 |issue=1 Suppl 1 |pages=S17–25, v–vi |year=2006 |pmid=16545629 |doi=10.1016/j.ccm.2005.08.001 |url=}}</ref><ref name="pmid21996929">{{cite journal |vauthors=Neghab M, Mohraz MH, Hassanzadeh J |title=Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust |journal=J Occup Health |volume=53 |issue=6 |pages=432–8 |year=2011 |pmid=21996929 |doi= |url=}}</ref>
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +/-
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Occupational history
** Sandblasting
** Bystanders
** Quartzite miller
** Tunnel workers
** Silica flour workers
** Workers in the scouring powder industry
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |
**Hyperresonant
**Fine [[crackles]]
**Rhonchi
**Bronchial breath sounds
**Expiratory wheezing
**Increased [[tactile fremitus]].
**Loud P2
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Increased susceptiblity to [[tuberculosis]].
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*[[Respiratory acidosis]]
*[[Abnormal sputum]]
*[[Anemia]]
*[[Neutrophilia]]
*Elevated [[ESR]]
*Elevated [[CRP]]
*Elevated [[immunoglobulin]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Small round opacities
** Symmetrically distributed
** Upper-zone predominance
* Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Nodular changes in lung parenchyma
* Progressive massive fibrosis
* Bullae, emphysema
* Pleural, mediastinal, and hilar changes
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Biopsy|Lung biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Asbestosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Shipyard workers
* Pipe fitting
* Insulators
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Lung cancer]]
* [[Mesothelioma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Predilection to lower lobes
* Fine and coarse linear, peripheral, reticular opacities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Subpleural linear opacities seen parallel to the pleura
* Basilar lung fibrosis
* Peribronchiolar, intralobular, and interlobular septal fibrosis;
* Honeycombing
* Pleural plaques.
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Berylliosis]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Electronic manufactures
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Hilar adenopathy
* Increased interstitial markings.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Ground glass opacification
* Parenchymal nodules
* Septal lines
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Byssinosis]] 
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Cotton wool workers
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Increased susceptibility to ''[[Actinomyces]]'' and ''[[Aspergillus]]'' infection.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Diffuse air-space consolidation
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Pulmonary fibrosis with honeycombing
* Peri bronchovascular distribution of nodules
* Ground-glass attenuations
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Sarcoidosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* African Americans
* [[Autoimmune]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Usually normal
* Occasional crackles
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Dermatological lesions|Dermatologic manifestations]]
* Ocular involvement
* Osseous involvement
* Heart failure from [[cardiomyopathy]]
* Lymphocytic [[meningitis]]
* [[Cranial nerve palsies]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Hypercalcemia]] or [[hypercalciuria]] 
* Elevated [[Vitamin D|1, 25-dihydroxyvitamin D levels]]
* Elevated [[angiotensin-converting enzyme]] (ACE)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Bilateral hilar lymphadenopathy
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* High-resolution CT (HRCT) scanning of the chest may identify
** Active alveolitis
** Fibrosis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Pleural effusion|Pleural Effusion]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |'''Transudate'''
* [[Congestive heart failure|CHF]]
* [[Cirrhosis]]
'''Exudate'''
* [[Parapneumonic effusion|Parapneumonic causes]] 
* [[Malignancy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+/-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Decreased [[tactile fremitus]] 
* Diminished or inaudible [[breath sounds]]
* Pleural [[friction rub]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Peripheral edema, distended neck veins, and S<sub>3</sub> gallop suggest [[congestive heart failure]].
* Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
* Cutaneous changes and ascites suggest liver disease.
* Lymphadenopathy or a palpable mass suggests malignancy.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Thoracentesis 
** [[Exudate]]
** [[Transudate]]
** [[LDH]], [[glucose]], [[cytology]]
* Other specific labs of underlying etiology
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Supine
* Blunting of the costophrenic angle
* Homogenous increase in density spread over the lower lung fields
Lateral decubitus
* Free flowing effusion as layers
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Thickened pleura
* Mild effusions can aslo be detected
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Thoracocentesis]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |Interstitial (Nonidiopathic) [[Idiopathic pulmonary fibrosis|Pulmonary Fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ++
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Connective tissue disorder|Connective-tissue disorder]]
* [[Pneumoconiosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Wheezing]]
* [[S3]]
* [[P2]]
* End-inspiratory rales
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Increased A-a gradient
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[ESR]]
* Serologic testing for [[ANA]], [[RF]], [[Anti-neutrophil cytoplasmic antibody|ANCA]] & ASCA may be positive
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Reticular and/or nodular opacities
* Honeycomb appearance (late finding)
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Bilateral reticular and nodular interstitial infiltrates
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Video-assisted thoracoscopic lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Interstitial Pneumonia|Lymphocytic Interstitial Pneumonia]]<ref name="pmid10397102">{{cite journal |vauthors=Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H |title=Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT |journal=AJR Am J Roentgenol |volume=173 |issue=1 |pages=71–4 |year=1999 |pmid=10397102 |doi=10.2214/ajr.173.1.10397102 |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Autoimmune]]
* [[Lymphoproliferative disorders]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Wheezing]]
* [[Rales]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Increased A-a gradient
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Polyclonal hypergammaglobulinemia
* Increased [[LDH]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Bibasilar interstitial or micronodular infiltrates
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Determines the degree of fibrosis
* Cysts (characterstic)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Open lung biopsy
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Obesity]]<ref name="pmid21116339">{{cite journal |vauthors=Zammit C, Liddicoat H, Moonsie I, Makker H |title=Obesity and respiratory diseases |journal=Int J Gen Med |volume=3 |issue= |pages=335–43 |year=2010 |pmid=21116339 |pmc=2990395 |doi=10.2147/IJGM.S11926 |url=}}</ref><ref name="O’Neill2015">{{cite journal|last1=O’Neill|first1=Donal|title=Measuring obesity in the absence of a gold standard|journal=Economics & Human Biology|volume=17|year=2015|pages=116–128|issn=1570677X|doi=10.1016/j.ehb.2015.02.002}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Overweight
* [[Diabetes mellitus]]
* [[Asthma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Wheezing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Polycythemia|Increased hematocrit]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* X ray findings are often limited due to body habitus
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* CT findings are variable and depends upon severity of obesity
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| colspan="2" |[[Eosinophilia|Pulmonary Eosinophilia]]<ref name="pmid19706907">{{cite journal |vauthors=de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML |title=Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma |journal=Am. J. Trop. Med. Hyg. |volume=81 |issue=3 |pages=424–7 |year=2009 |pmid=19706907 |doi= |url=}}</ref>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Infections
* [[Parasitic]]
* [[Fungal]]
* [[Mycobacterial]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Wheezing]]
* [[Rales]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Increased A-a gradient
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Leukocytosis]] with [[eosinophilia]] (> 250/µL)
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
* Interstitial or diffuse nodular densities
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Determines extent and distribution of the disease
* Interstitial infiltrates
* Cysts and nodules
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |''↓''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Biopsy of lesion (skin or lung)
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
| rowspan="4" |Neuromuscular disease
|Scoliosis
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Postural abnormality
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* R/0 genetic conditions
** [[Marfan's syndrome]]
** [[Edwards syndrome|Edward's syndrome]]
* Total [[Lymphocyte|lymphocyte count]] (should be >1500/μL)
* Nutritional status must be assessed
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Clinical
* Radiographs
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Muscular dystrophy]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Proximal muscle weakness
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Rash]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Elevated [[CPK]] and [[aldolase]]
* [[Antinuclear antibodies|+ANA]]
* +Anti-Jo abs
* Elevated [[ESR]], [[C-reactive protein|CRP]] and [[RF]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Muscle biopsy]]
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[ALS]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Muscle weakness
* Neurological deficit
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
* Cognitive or behavioral dysfunction
* Sensory nerves and the autonomic nervous system are generally unaffected
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/A
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Not significant/diagnostic
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Not significant/diagnostic
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>-</nowiki>
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Clinical diagnosis
* Nerve conduction studies and needle [[electromyography]] (EMG) 
|- style="background: #DCDCDC; padding: 5px; text-align: center;" |
|[[Myasthenia gravis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |H/O of difficulty getting up from chair
* Combing
* [[Dysphagia|Difficulty in swallowing]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Decreased [[breath sounds]]
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Extraocular, bulbar, or proximal limb muscles.
* Breathing as rapid and shallow
* Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* Anti–acetylcholine receptor (AChR) antibody (Ab) test +
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Thymoma]] as an anterior mediastinal mass.
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Thymoma]] as an anterior mediastinal mass.
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |N
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
* [[Electromyography]]
|}
{| class="wikitable"
|}


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Occupational Hazard]]
{{Respiratory pathology}}
{{SIB}}


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 19:34, 19 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The differential diagnosis of hypersensitivity pneumonitis is, primarily, a group of diseases known as idiopathic interstitial pneumonia. This group of diseases includes idiopathic pulmonary fibrosis (IPF) (which manifests histologically as usual interstitial pneumonia), idiopathic non-specific interstitial pneumonia (NSIP) and cryptogenic organizing pneumonia, among others. There are several important clinical syndromes that occur as a result of inhalation of organic agents but are not true forms of Hypersensitivity Pneumonitis.

Differential Diagnosis

  • HP occurs due to inhalation of organic agents .
  • Several diseases can occur due to this and mimic HP.
  • These disorders are as follows:
    • Inhalation fever:
      • Patients present with fever, chills, headache, and myalgias.
      • There are no pulmonary findings (although mild dyspnea may occur).[1]
      • Onset is 4-8 hours following exposure.
      • No long-term symptoms.
    • Organic dust toxic syndrome:
      • This syndrome occurs due to of exposure to bioaerosols contaminated with toxin-producing fungi (mycotoxins).[2][3][4]
      • Patients present with fever, chills, and myalgias 4-6 hours after exposure. [5]
      • In contrast to inhalation fever, the chest X ray may show diffuse opacities.
      • Bronchiolitis or diffuse alveolar damage may be present on lung biopsy specimens.
      • This is not a true form of HP because no prior sensitization is required.
    • Chronic bronchitis:
      • This is a very severe form of pulmonary disease.
      • Most common respiratory disorder among agricultural workers.
      • The prevalence of chronic bronchitis is much higher at 10%, compared with 1.4% for HP.
    • Exposure to aerosolized Mycobacterium avium complex (MAC):
      • Occurs due to exposure to aerosolized mycobacterium avium complex (MAC).
      • Hot tub lung is a term used to describe these hypersensitivity pneumonitis-like cases because they have generally been associated with hot tub use.
      • The syndrome has been linked to the high levels of infectious aerosols containing MAC organisms found in the water. Whether this syndrome represents a true MAC infection or classic HP remains controversial (Marras, 2005).

By frequency of Interstitial Lung Diseases (Xaubet, 2004):

  1. Idiopathic pulmonary fibrosis (38.6%)
  2. Sarcoidosis (14.9%)
  3. Cryptogenic organizing pneumonia (10.4%)
  4. Interstitial lung disease associated with collagen vascular diseases (9.9%)
  5. Hypersensitivity Pneumonitis (HP) (6.6%)
  6. Unclassified (5.1%)

In alphabetical order:

Restrictive lung disease must be differentiated from other diseases that cause dyspnea, cough, hemoptysis, and fever such as ARDS, bronchitis, hypersensitivity pneumonitis, pneumoconiosis.

Pulmonary Function Test Obstructive Lung Disease Restrictive Lung Disease
TLC
RV
FVC
FEV1 ↓↓
FEV1/FVC N to
MVV

Approach to Lung Disorders

 
 
 
 
 
 
 
 
 
 
 
 
 
Spirometry
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal to high FEV1/FVC ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obstructive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
Restrictive Lung Disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bronchodilator therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased FEV1
 
 
 
 
 
 
 
No change in FEV1
 
 
 
Normal DLCO
 
 
 
 
 
 
 
Decreased DLCO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asthma
 
 
 
 
 
 
 
COPD
 
 
 
Chest wall disorders
 
 
 
 
 
 
 
Interstitial Lung Disease
 
 


Spirometry Findings in Various Lung Conditions

Spirometry showing Obstructive and Restrictive Lung Disease ([Source:By CNX OpenStax [CC BY 4.0 (http://creativecommons.org/licenses/by/4.0)], via Wikimedia Commons])
Disease Clinical manifestations Diagnosis
Symptoms Physical exam Lab findings Imaging Gold standard
Cough Dyspnea Hemoptysis Fever History/Exposure Cyanosis Clubbing JVD Peripheral edema Auscultation Other prominent findings CXR CT DLCco
Hypersensitivity Pneumonitis + + - + - + - -
  • Constitutional symptoms
  • Poorly defined micronodular or diffuse interstitial pattern
  • In chronic form
    • Fibrosis
    • Loss of lung volume
    • Coarse linear opacities
  • Ground-glass opacities or
  • Diffusely increased radiodensities
  • Diffuse micronodules
  • Focal air trapping
  • Mosaic perfusion
  • Occasionaly thin-walled cysts
  • Mild fibrotic changes 
  • Clinical diagnosis
Acute Respiratory Distress Syndrome (ARDS) - + - - + - - -
  • Bilateral pulmonary infiltrates
    • Initially patchy peripheral
    • Later diffuse bilateral
  • Ground glass
  • Frank alveolar infiltrate
  • Bronchial dilatation within areas of ground-glass opacification
  • PaO2 / FiO2 <300
Bronchitis Acute + - +/- + - - - - -
  • Diffuse wheezes
  • High-pitched continuous sounds
  • The use of accessory muscles 
  • Prolonged expiration
  • Rhonchi
  • Rales
  • N/A
  • Normal
  • N/A
-
  • Clinical diagnosis
Chronic + + - -
  • A positive history of chronic productive cough 
  • Shortness of breath 
+ - + +
  • Prolonged expiration; wheezing
  • Diffusely decreased breath sound
  • Coarse crackles with inspiration
  • Coarse rhonchi
  • N/A
  • Radiolucency
  • Diaphragmatic flattening due to hyperinflation
  • Increased retrosternal airspace on the lateral radiograph
  • N/A
  • N/A
Pneumoconiosis[6] SIlicosis[7][8] + + +/- -
  • Occupational history
    • Sandblasting
    • Bystanders
    • Quartzite miller
    • Tunnel workers
    • Silica flour workers
    • Workers in the scouring powder industry
+ + + -
  • Small round opacities
    • Symmetrically distributed
    • Upper-zone predominance
  • Diffuse interstitial pattern of fibrosis without the typical nodular opacities in chronic case
  • Nodular changes in lung parenchyma
  • Progressive massive fibrosis
  • Bullae, emphysema
  • Pleural, mediastinal, and hilar changes
Asbestosis
  • Shipyard workers
  • Pipe fitting
  • Insulators
  • Predilection to lower lobes
  • Fine and coarse linear, peripheral, reticular opacities
  • Subpleural linear opacities seen parallel to the pleura
  • Basilar lung fibrosis
  • Peribronchiolar, intralobular, and interlobular septal fibrosis;
  • Honeycombing
  • Pleural plaques.
Berylliosis 
  • Electronic manufactures
-
  • Hilar adenopathy
  • Increased interstitial markings.
  • Ground glass opacification
  • Parenchymal nodules
  • Septal lines
Byssinosis 
  • Cotton wool workers
  • Diffuse air-space consolidation
  • Pulmonary fibrosis with honeycombing
  • Peri bronchovascular distribution of nodules
  • Ground-glass attenuations
Sarcoidosis + + + + - - - -
  • Usually normal
  • Occasional crackles
  • Bilateral hilar lymphadenopathy
  • High-resolution CT (HRCT) scanning of the chest may identify
    • Active alveolitis
    • Fibrosis
Pleural Effusion + + +/- +/- Transudate

Exudate

+/- +/- +/- +/-
  • Peripheral edema, distended neck veins, and S3 gallop suggest congestive heart failure.
  • Edema may also be a manifestation of nephrotic syndrome, pericardial disease, or, when combined with yellow nailbeds, the yellow nail syndrome.
  • Cutaneous changes and ascites suggest liver disease.
  • Lymphadenopathy or a palpable mass suggests malignancy.
Supine
  • Blunting of the costophrenic angle
  • Homogenous increase in density spread over the lower lung fields

Lateral decubitus

  • Free flowing effusion as layers
  • Thickened pleura
  • Mild effusions can aslo be detected
Interstitial (Nonidiopathic) Pulmonary Fibrosis + ++ + - + + + +
  • Increased A-a gradient
  • Elevated ESR
  • Serologic testing for ANA, RF, ANCA & ASCA may be positive
  •  Reticular and/or nodular opacities
  • Honeycomb appearance (late finding)
  • Bilateral reticular and nodular interstitial infiltrates
Video-assisted thoracoscopic lung biopsy
Lymphocytic Interstitial Pneumonia[9] + + + + - + - -
  • Increased A-a gradient
  • Polyclonal hypergammaglobulinemia
  • Increased LDH
  • Bibasilar interstitial or micronodular infiltrates
  • Determines the degree of fibrosis
  • Cysts (characterstic)
N Open lung biopsy
Obesity[10][11] + + - - - - - + -
  • X ray findings are often limited due to body habitus
  • CT findings are variable and depends upon severity of obesity
N Clinical
Pulmonary Eosinophilia[12] + + + + Infections + - + +
  • Increased A-a gradient
  • Interstitial or diffuse nodular densities
  • Determines extent and distribution of the disease
  • Interstitial infiltrates
  • Cysts and nodules
Biopsy of lesion (skin or lung)
Neuromuscular disease Scoliosis - + - -
  • Postural abnormality
- - - -
  • In severe scoliosis, the rib cage may press against the lungs making it more difficult to breathe.
  • Accurate depiction of the true magnitude of the spinal deformity can be assessed by supine anteroposterior (AP) and lateral spinal radiographs
  • N/A
N
  • Clinical
  • Radiographs
Muscular dystrophy - + - -
  • Proximal muscle weakness
- - - -
  • N/A
  • N/A
N
ALS - + - -
  • Muscle weakness
  • Neurological deficit
- - - -
  • Symptoms begin with limb involvement diue to muscle weakness and atrophy. 
  • Cognitive or behavioral dysfunction
  • Sensory nerves and the autonomic nervous system are generally unaffected
N/A Not significant/diagnostic Not significant/diagnostic -
Myasthenia gravis - + - + H/O of difficulty getting up from chair - - - -
  • Extraocular, bulbar, or proximal limb muscles.
  • Breathing as rapid and shallow
  • Respiratory muscle weakness can lead to acute respiratory failure may require immediate intubation.
  • Anti–acetylcholine receptor (AChR) antibody (Ab) test +
  • Thymoma as an anterior mediastinal mass.
  • Thymoma as an anterior mediastinal mass.
N

References

  1. Antonini JM, Lewis AB, Roberts JR, Whaley DA (April 2003). "Pulmonary effects of welding fumes: review of worker and experimental animal studies". Am. J. Ind. Med. 43 (4): 350–60. doi:10.1002/ajim.10194. PMID 12645092.
  2. Lougheed MD, Roos JO, Waddell WR, Munt PW (November 1995). "Desquamative interstitial pneumonitis and diffuse alveolar damage in textile workers. Potential role of mycotoxins". Chest. 108 (5): 1196–200. PMID 7587416.
  3. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA (July 1996). "Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects". Chest. 110 (1): 263–70. PMID 8681637.
  4. Emanuel DA, Wenzel FJ, Lawton BR (March 1975). "Pulmonary mycotoxicosis". Chest. 67 (3): 293–7. PMID 46192.
  5. Malmberg P, Rask-Andersen A, Rosenhall L (April 1993). "Exposure to microorganisms associated with allergic alveolitis and febrile reactions to mold dust in farmers". Chest. 103 (4): 1202–9. PMID 8131466.
  6. Gay SE, Kazerooni EA, Toews GB, Lynch JP, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, Popovich J, Hyzy R, Martinez FJ (1998). "Idiopathic pulmonary fibrosis: predicting response to therapy and survival". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1063–72. doi:10.1164/ajrccm.157.4.9703022. PMID 9563720.
  7. du Bois RM (2006). "Evolving concepts in the early and accurate diagnosis of idiopathic pulmonary fibrosis". Clin. Chest Med. 27 (1 Suppl 1): S17–25, v–vi. doi:10.1016/j.ccm.2005.08.001. PMID 16545629.
  8. Neghab M, Mohraz MH, Hassanzadeh J (2011). "Symptoms of respiratory disease and lung functional impairment associated with occupational inhalation exposure to carbon black dust". J Occup Health. 53 (6): 432–8. PMID 21996929.
  9. Honda O, Johkoh T, Ichikado K, Tomiyama N, Maeda M, Mihara N, Higashi M, Hamada S, Naito H, Yamamoto S, Nakamura H (1999). "Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT". AJR Am J Roentgenol. 173 (1): 71–4. doi:10.2214/ajr.173.1.10397102. PMID 10397102.
  10. Zammit C, Liddicoat H, Moonsie I, Makker H (2010). "Obesity and respiratory diseases". Int J Gen Med. 3: 335–43. doi:10.2147/IJGM.S11926. PMC 2990395. PMID 21116339.
  11. O’Neill, Donal (2015). "Measuring obesity in the absence of a gold standard". Economics & Human Biology. 17: 116–128. doi:10.1016/j.ehb.2015.02.002. ISSN 1570-677X.
  12. de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML (2009). "Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma". Am. J. Trop. Med. Hyg. 81 (3): 424–7. PMID 19706907.


Template:WikiDoc Sources